WHO ICTRP trial
Effects of remazolam on cerebral oxygen saturation and postoperative cognitive…
ChiCTR2500106681 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500106681 |
|---|---|
| Public title | Effects of remazolam on cerebral oxygen saturation and postoperative cognitive function in elderly patients undergoing laparoscopic radical surgery for colorectal cancer |
| Scientific title | Effects of remazolam on cerebral oxygen saturation and postoperative cognitive function in elderly patients undergoing laparoscopic radical surgery for colorectal cancer |
| Primary sponsor | Linyi People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | colorectal cancer |
| Interventions | Rimazolam group:Group R was induced with remazolam (0.3-1 mg/kg) combined with sufentanil (0.3 µg/kg) with cis-atracurium (0.15 mg/kg);Propofol group:In group P, propofol (2-4 mg/kg) combined with sufentanil (0.3 µg/kg) with cis-atracurium… |
| Registration date | Jul 28, 2025 |
| Target size | Rimazolam group:40;Propofol group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: